Loratadine
Brand names: Clarityn, Benadryl Once A Day
Loratadine is a non-sedating second-generation oral antihistamine used for allergic rhinitis and chronic urticaria.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It is a selective peripheral histamine H1-receptor antagonist that blocks histamine-mediated allergic responses while crossing the blood-brain barrier poorly, limiting sedation.
Prescribing in practice
- It is generally well tolerated and only mildly sedating, but advise caution as a minority of patients still experience drowsiness affecting driving or skilled tasks.
- Dose adjustment may be needed in significant hepatic impairment.
- Antihistamines are usually withheld before allergy skin testing as they can suppress the response.
Monitoring
No routine monitoring is required for this generally well-tolerated antihistamine.
Counselling the patient
- It is usually taken once daily and is less likely to cause drowsiness than older antihistamines.
- It can be taken with or without food.
- Tell your clinician if symptoms persist despite treatment.
Evidence & guidelines
Non-sedating antihistamines such as loratadine are recommended first-line in NICE guidance for allergic rhinitis and chronic urticaria.
Reference: NICE CG134 (Allergic Rhinitis); Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Sepsis Screening and Sepsis Six · UK Sepsis Trust; NICE NG51; Surviving Sepsis Campaign 2021
- Unintentional Weight Loss Workup · NICE NG12; BSG
- Chronic Fatigue Workup · NICE NG206; BMJ Best Practice
- Lymphadenopathy Workup · NICE NG12; BMJ Best Practice
- Pre-op Medical Clearance · NICE NG45; ESC 2022
- Secondary Hypertension Workup · NICE NG136; ESH 2023